[1]From the Interventional Radiology Service, Memorial Sloan Kettering Cancer Center,
1275 York Ave, H-118, New York, NY 10065 (J.P.E.); Department of Radiology and Imaging
Sciences, University of Utah School of Medicine, Salt Lake City, Utah (G.C.F.); Department
of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
(G.J.A., M.d.B.); Department of Radiology, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Mass (M.A.); Division of Vascular and Interventional Radiology,
Department of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven,
Conn (J.C.); Department of Radiodiagnostic and Interventional Radiology, University
of Lausanne, Lausanne, Switzerland (R.D.); Penn Image-Guided Interventions Laboratory
and Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia,
Pa (S.J.H.); Department of Radiology, University of Colorado, Denver, Colo (D.T.J.);
Department of Radiology, Ludwig-Maximilian University, Munich, Germany (J.R.); Division
of Vascular and Interventional Radiology, Stanford University, Stanford, Calif (D.Y.S.);
Division of Interventional Radiology, Mayo Clinic Florida, Jacksonville, Fla (B.B.T.);
Center for Interventional Oncology, National Cancer Institute, Radiology and Imaging
Sciences, National Institutes of Health Clinical Center, Bethesda, Md (B.J.W.); Department
of Radiology, Mayo Clinic, Rochester Minn (D.W.); and Department of Radiology, Hadassah
Hebrew University Medical Center, Jerusalem, Israel (S.N.G.).